PUBH5010 Epidemiology Methods and Uses
PUBH5010 Overview
- University of Sydney
- S1 2026
- 10 chapters
- Health and Medicine
Epidemiology Methods and Uses is the University of Sydney's core Master of Public Health methods subject — it teaches how to read, build and judge a study: the design tree, measures of frequency and association, the 2×2 table that the whole paper radiates from, selection bias, confounding and standardisation, measurement error, critical appraisal, randomised controlled trials, screening and diagnostic tests, and systematic reviews and causation.
- Assessed by Final exam 60–85% · Mid-semester assignment 25% / 0% · Online quizzes 10% · Tutorial tasks 5% — Final exam is a hurdle
- Key terms Risk ratio (RR), Odds ratio (OR), Confounding, Non-differential misclassification
- How to prepare Make the 2×2 table your reflex: nearly every Section-A and Section-B prompt reduces to “name the design, build the 2×2…
- Most asked Is the PUBH5010 exam open or closed book?
How PUBH5010 is assessed
| Component | Weight | Format |
|---|---|---|
| Final exam · hurdle | 60–85% | Exam period · in-person, open book with a supplied formula sheet · 2 h + 10 min reading · three sections (A short / B scenario / C long study) · non-programmable calculator, no AI · HURDLE: must score ≥50% on the exam to pass |
| Mid-semester assignment | 25% / 0% | Critically appraise a paper — hypothesis type, study design, calculate & interpret the measures, identify bias (counts under one of two mark schemes, whichever is greater) |
| Online quizzes | 10% | Weekly Canvas quizzes — best 10 of 12 counted |
| Tutorial tasks | 5% | Short in-class tasks across the semester — attemptable only if you attend; confirm this year's exact split on Canvas |
What PUBH5010 covers
Ten teaching blocks → one open-book exam-ready map. Each links to its free chapter guide.
Study Types and the Design Tree
Descriptive vs analytic · ecological / cross-sectional / case-control / cohort / RCT · the study baseThis is the decision that opens almost every exam prompt: what kind of study is this? Epidemiological designs split first into descriptive (who, where, when — no comparison group) and analytic (a comparison that lets you test an exposure–outcome link), and the analytic branch then splits by who decided who got the exposure.
- Descriptive vs analytic: when there is a comparison group, and when there isn't
- Experimental vs observational: who allocated the exposure
- Cohort studies: group by exposure, follow forward to the outcome
- Case-control studies: group by outcome, look back at exposure
- Cross-sectional and ecological designs, and the ecological fallacy
- The study base, and why a well-defined base matters
Measures of Frequency
Ratio / proportion / rate · point & period prevalence · cumulative incidence & incidence rate · person-timeBefore you can compare two groups you have to count disease correctly, and the first question is always which denominator are you dividing by? A ratio divides two unrelated quantities; a proportion is a ratio whose numerator is part of its denominator (so it runs 0–1); a rate divides events by the person-time at risk and carries units of 1/time.
- Ratio vs proportion vs rate, and the units each carries
- Point prevalence and period prevalence
- Cumulative incidence (a risk) and the at-risk denominator
- The incidence rate and the person-time denominator
- Computing person-time from individual follow-up
- Prevalence ≈ incidence × duration, and what it implies
Measures of Association and the 2×2 Table
RR · RD · OR · which measure for which design · attributable & population-attributable fractionsThis is the engine of the whole paper: nearly every analytic answer starts by laying out the exposure × outcome 2×2 table — cells a, b, c, d — and then choosing the right number to radiate out of it.
- The exposure × outcome 2×2 table and cells a, b, c, d
- Risk ratio (RR) and risk difference (RD) from a cohort or RCT
- The odds ratio (OR) from a case-control study, and when OR ≈ RR
- Ratio vs absolute measures, and what the null value is for each
- Number needed to treat / harm: NNT = 1/RD
- Attributable fraction in the exposed
Selection Bias
Selection of cases & controls · healthy-worker effect · loss to follow-up · how it distorts the measureSelection bias arises when the people you actually analysed are not a fair window on the study base — the source population the question is really about — so the association you measure is distorted before any calculation.
- What selection bias is: the analysed sample vs the study base
- Selection of inappropriate controls in case-control studies
- The healthy-worker effect
- Loss to follow-up related to exposure and outcome
- Volunteer, referral and survivor effects
- Predicting the direction of the distortion
Confounding, Effect Modification and Standardisation
The three criteria · the direction of bias · effect modification vs confounding · direct & indirect standardisationConfounding is the third explanation for an association: a variable that is (1) associated with the exposure, (2) an independent risk factor for the outcome, and (3) not on the causal pathway between them, which mixes its own effect into the crude estimate.
- The three criteria that define a confounder
- Reasoning the direction of confounding bias
- Controlling confounding by design: restriction and matching
- Controlling confounding in analysis: stratification and Mantel–Haenszel
- Effect modification vs confounding — report vs adjust
- Direct standardisation and the standardised rate
Measurement Error and Misclassification
Differential vs non-differential error · bias toward the null · exposure vs outcome misclassification · sensitivity & specificity of an instrumentIf you mis-measure exposure or outcome, the number you report is the wrong number — and the key exam skill is predicting which way it goes wrong.
- Validity vs reliability of a measurement
- Misclassification of a categorical variable
- Non-differential error and the bias toward the null
- Differential error and recall bias — direction unpredictable
- Exposure vs outcome misclassification
- Sensitivity and specificity of a measurement instrument
Critical Appraisal
The Section-C pipeline · selection → measurement → confounding → chance · which flaw matters mostThe long Section-C question hands you a realistic study and asks: can I believe this result? Critical appraisal is the repeatable pipeline that answers it, and the exam reward is structure, not free-form criticism.
- Framing the question: design, hypothesis, and the measure reported
- Could chance explain it? Precision, confidence intervals, p-values
- Selection: is the sample a fair window on the study base?
- Measurement / information: validity and the direction of misclassification
- Confounding: the three criteria and the direction of bias
- Weighing which flaw matters most
Randomised Controlled Trials
Randomisation, allocation concealment, blinding & placebo · intention-to-treat vs per-protocol · efficacy vs effectivenessThe RCT is the design that earns a causal claim, because the investigator allocates the exposure — ideally at random — so that, on average, the groups differ only in the treatment.
- Why randomisation earns causation: balancing known and unknown confounders
- Allocation concealment vs randomisation — protecting entry
- Blinding/masking: participants, carers, assessors — protecting after entry
- The role of a placebo and the placebo effect
- Intention-to-treat: preserving randomisation, the conservative estimate
- Per-protocol analysis and why it can reintroduce bias
Screening and Diagnostic Tests
The diagnostic 2×2 · sensitivity / specificity / PPV / NPV & prevalence · Wilson & Jungner · lead- & length-time biasEvaluating a test reduces to a second 2×2 — the diagnostic table — with a strict reading rule: columns are accuracy, rows are predictive value.
- The diagnostic 2×2: columns = accuracy, rows = predictive value
- Sensitivity and specificity as intrinsic test properties
- Positive and negative predictive value, read across the rows
- Why PPV and NPV depend on prevalence
- The sensitivity–specificity trade-off and the cut-off
- Wilson & Jungner principles for justified screening
Systematic Reviews, Meta-Analysis and Causation
From many studies to one pooled estimate · reading a forest plot · heterogeneity · the Bradford Hill considerationsThe final block turns a pile of individual studies into one defensible conclusion.
- Systematic review vs narrative review: the explicit protocol
- Meta-analysis: pooling studies into one weighted estimate
- Reading a forest plot: boxes, lines, the diamond and the line of no effect
- Heterogeneity and when pooling is (in)appropriate
- Publication bias
- Association is necessary but not sufficient for causation
The final exam is open book with a supplied “Helpful Formulae” sheet, so the equations are handed to you and the marks live in judgement — which measure, which bias, which direction, and the one plain-English sentence a layperson would understand. It is also a hurdle: you must score at least 50% on the exam itself to pass the subject.
This guide drills exactly that recurring answer shape: name the design → build the 2×2 → pick & compute the measure → interpret in plain words.
Worked example · free
Build the 2×2 and pick the right measure — the Section-B centrepiece, mark by mark
- +1Build the 2×2. Exposed: a=120 with the outcome, b=880 without (1,000 total). Unexposed: c=60, d=940. Cells a/b/c/d are the engine the measures radiate from.
- +1Risks in each arm. Exposed risk R₁ = a/(a+b) = 120/1000 = 0.12; unexposed risk R₀ = c/(c+d) = 60/1000 = 0.06. (Cumulative incidence, because the follow-up is complete.)
- +1Risk ratio. RR = R₁/R₀ = 0.12/0.06 = 2.0. Use the RR (not the OR) because this is a cohort — you can measure risk directly.
- +1Risk difference and NNH. RD = R₁ − R₀ = 0.12 − 0.06 = 0.06; number needed to harm = 1/RD = 1/0.06 ≈ 17.
- +2Interpret in plain words. The exposed group had twice the risk (a 100% higher risk) of the outcome — not “two times higher”, which would imply three times the risk.
Key terms
- Risk ratio (RR)
- The risk of the outcome in the exposed group divided by the risk in the unexposed group, R₁/R₀, computed straight from the 2×2 a/(a+b) over c/(c+d). It is the right measure for a cohort or RCT, where risk can be observed directly; RR = 1 means no association. Interpret it as “twice the risk”, never “two times higher”.
- Odds ratio (OR)
- The odds of exposure (or outcome) in one group over the other, ad/bc on the 2×2. It is the measure a case-control study licenses, because cases and controls are sampled on the outcome so risk cannot be read off directly. For a rare outcome the OR approximates the RR; for a common one it overstates it.
- Confounding
- A third factor associated with both the exposure and the outcome, and not on the causal pathway between them, that distorts the observed association. It must meet three criteria, and the examiner wants the direction of the distortion — whether it pulls the estimate away from or toward the null — not just the label.
- Non-differential misclassification
- Measurement error that is the same in the groups being compared (e.g. exposure mis-measured equally in cases and controls). For a binary exposure it characteristically biases the estimate toward the null — it dilutes a real association — which is why it is the safer direction to predict in Section C.
- Sensitivity and specificity
- Properties of a screening or diagnostic test read down the columns of the diagnostic 2×2: sensitivity = the proportion of true cases the test catches; specificity = the proportion of true non-cases it correctly clears. They are intrinsic to the test; predictive values (PPV/NPV), read across the rows, also depend on the prevalence of disease.
PUBH5010 FAQ
Is PUBH5010 hard?
It is concept-dense rather than maths-heavy: the calculations are short (risks, RR, OR, RD, NNT, sensitivity/specificity), and because the exam is open book with a supplied formula sheet, the difficulty is judgement under time — choosing the right measure, naming the right bias, calling its direction, and writing the clean plain-English sentence.
The exam is also a 50% hurdle, so the stakes are concentrated on one open-book paper.
How is PUBH5010 assessed?
By a final exam (worth 60–85% under whichever of two mark schemes is greater), a mid-semester critical-appraisal assignment (25% or 0%), weekly online quizzes (10%, best 10 of 12), and short in-class tutorial tasks (5%). The exam carries a hurdle: you must score at least 50% on it to pass the subject. Confirm this year's exact weights, dates and conditions on Canvas.
Is the PUBH5010 exam open or closed book?
Open book. It is sat in person over 2 hours of writing plus 10 minutes of reading time, in three sections (A short answers, B a scenario, C a long study to appraise), with a supplied “Helpful Formulae” sheet and a non-programmable calculator allowed. No AI or other electronic aids are permitted. Because the formulas are handed to you, the marks are in judgement and speed, not recall.
What is on the PUBH5010 final exam?
Naming study designs from a cue; computing and interpreting measures of frequency and association from a 2×2 (RR, RD, OR, NNT); identifying and giving the direction of selection bias, confounding and measurement error; the critical-appraisal pipeline on a long study; RCT concepts (intention-to-treat, blinding); and screening and diagnostic-test evaluation (sensitivity, specificity, PPV).
The plain-words interpretation of every number carries marks.
Is using AskSia for PUBH5010 cheating?
No. AskSia is a study reference written in our own words — we host none of your lecturer's files, every worked example uses our own invented numbers, and we never reproduce a past paper's stem or data. Sia teaches you the method to earn the marks; it does not complete or sit your assessments. (The exam itself bans AI in the room — this guide is for your preparation beforehand.)
Questions students ask in each PUBH5010 chapter
- How do I tell a cohort from a case-control study?
- Ask what defined the groups. If people were grouped by their exposure and then followed forward to see who got the outcome, it is a cohort (group by exposure, measure RR). If people were chosen because they already had the outcome (cases) or did not (controls), and exposure was asked about afterwards, it is a case-control (group by outcome, measure OR). The direction of sampling, not the timing of data collection, is the tell. Chapter 01 · Study Types and the Design Tree
- What's the difference between prevalence and incidence?
- Prevalence counts all existing cases (old and new) at a point in time, as a proportion of the population — it measures the burden of disease. Incidence counts only new cases over a period — it measures the risk or rate of getting the disease. A long-lasting disease can have high prevalence but low incidence; a quickly-fatal or quickly-cured one can have high incidence but low prevalence. Chapter 02 · Measures of Frequency
- How do I know whether to use RR or OR?
- Let the design decide. A cohort or RCT lets you observe the risk of the outcome in each exposure group, so you can and should compute the risk ratio (and risk difference). A case-control study samples on the outcome, so risk is not observable and you must use the odds ratio. Reporting an OR from cohort data is a common slip the exam tests for. Chapter 03 · Measures of Association and the 2×2 Table
- How is selection bias different from confounding?
- Selection bias comes from how people entered or stayed in the study — the analysed sample is not a fair window on the study base. Confounding comes from a third variable mixed into a correctly-sampled comparison. The practical difference is fixability: confounding can often be adjusted for in the analysis if you measured the confounder; selection bias usually cannot, because the needed information was never sampled. Chapter 04 · Selection Bias
- What are the three criteria for a confounder?
- A confounder must be (1) associated with the exposure, (2) an independent risk factor for the outcome, and (3) not on the causal pathway between exposure and outcome. If a variable lies on the pathway (a mediator), adjusting for it would wrongly remove part of the real effect; that distinction is a favourite exam trap. Apply all three to the specific variable named in the question. Chapter 05 · Confounding, Effect Modification and Standardisation
- What's the difference between validity and reliability?
- Validity is about accuracy — does the instrument measure the true value (for a yes/no measure, captured by sensitivity and specificity)? Reliability is about consistency — does it give the same answer when repeated? A scale can be reliable but invalid (consistently 2 kg too high) or valid on average but unreliable (right on average, noisy each time). Epidemiological bias mostly flows from invalidity, especially misclassification. Chapter 06 · Measurement Error and Misclassification
- What order should I appraise a study in?
- Use a fixed pipeline so you never miss a step under time pressure: name the design and hypothesis; assess chance (confidence interval, p-value, precision); then the three validity threats — selection bias, measurement/information bias, and confounding — each with its likely direction; then weigh which matters most and give a calibrated bottom line. The fixed order is itself worth marks because it shows disciplined reasoning. Chapter 07 · Critical Appraisal
- Why does randomisation let an RCT claim causation?
- Because allocating treatment by chance balances confounders — crucially including ones you never measured or thought of — across the arms, so any outcome difference can be attributed to the treatment rather than to pre-existing group differences. Observational designs can only adjust for confounders they measured; randomisation handles the unknown ones too, which is why a well-run RCT gives the strongest causal evidence. Chapter 08 · Randomised Controlled Trials
- What's the difference between sensitivity/specificity and predictive values?
- Sensitivity and specificity are read down the columns (true disease status) and are intrinsic properties of the test — they do not change with how common the disease is. Predictive values (PPV, NPV) are read across the rows (test result) and answer the clinically useful question 'given this result, how likely is the disease?' — and they depend heavily on prevalence. The columns-vs-rows rule keeps the four quantities straight. Chapter 09 · Screening and Diagnostic Tests
- What makes a review 'systematic'?
- An explicit, reproducible method: a pre-specified question, a documented and comprehensive search strategy, clear inclusion and exclusion criteria applied consistently, and a structured critical appraisal of every included study. This transparency — anyone could repeat the process and get the same set of studies — is what separates a systematic review from a narrative review, where selection and emphasis are at the author's discretion and prone to bias. Chapter 10 · Systematic Reviews, Meta-Analysis and Causation
How to study for the exam
Make the 2×2 table your reflex: nearly every Section-A and Section-B prompt reduces to “name the design, build the 2×2, pick the measure it licenses, then say what the number means in plain words.” Because the exam is open book with a supplied formula sheet, do not waste revision copying equations — instead drill the decisions: cohort/RCT → RR & RD; case-control → OR; a third factor linked to both exposure and outcome → confounding (check the three criteria and call the direction); error the same in both groups → non-differential → bias toward the null.
Tab the book so the right page opens in seconds — open-book speed is a skill you practise. And rehearse the lay-sentence stems (“twice the risk”, never “two times higher”), because the interpretation marks are the ones most students drop. Since the exam is a 50% hurdle, banked interpretation and measure-choice marks are the safest marks in the subject.